Daunorubicin (DNR)

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
06991
The value of high dose versus standard dose Ara-c during induction and IL-2 after intensive consolidation/autologous stem cell transplantation in patients (age 15-60 yrs) with acute myelogenous leukemia. A randomized phase III trial of the EORTC and GIMEMA Leukemia Cooperative Groups (AML-12).
58051
International collaborative treatment protocol for infants under one year with acute lymphoblastic or biphenotypic leukemia
58951
The value of 1) Dexamethasone vs prednisolone during induction 2) of prolonged versus conventional duration of L-Asparaginase therapy during consolidation and late intensification, in acute lymphoblastics leukemia and lymphoblastic non-Hodgkin lymphoma of childhood. A Randomised phase III study.

Back to Protocol section